Radiologists at Dana-Farber Cancer Institute in Boston have been using the lesion management module of Carestream’s Vue PACS to gather information about tumors and analyze how they respond to treatment, the company has reported. The module is an embedded native application that doesn’t require a dedicated workstation and imports prior exam results from other vendors’ PACS platforms.
“Carestream’s lesion management tool delivers excellent quantitative analysis of lesions, specifically volumetric data, which has the potential to overcome some of the limitations of standard one-dimensional measurement techniques,” said Michael Rosenthal, MD, PhD, a radiologist at the Dana-Farber Cancer Institute and a professor at Harvard Medical School. “This tool also provides rapid, standardized segmentation and analysis, and could improve the consistency of interpretations.”
The tool is designed to improve the assessment of oncology patients by simplifying the segmentation and analysis process. The system provides volumetric data and makes it easier to compare different data sets. Bookmarking and tracking tools support patient follow-up and streamline workflow. One feature generates data by allowing physicians to draw a line across the longest dimension of the tumor, replacing a manual analytical technique that can take up to 45 minutes.
“Certainly the time savings is important, but what’s even more valuable is the ability to deliver consistent, repeatable measurements for each tumor,” Rosenthal said. “I see tremendous potential for this technology in evaluating tumors in oncology patients.”
For more information, visit Carestream.
Get AXIS e-newsletters free. Subscribe here.
